Nisha Shrestha Email

Senior Scientist . GO Therapeutics

Current Roles

Employees:
11
Revenue:
$1.7M
About
GO Therapeutics is exploiting unique aspects of cancer cell biology to develop a new class of cancer therapies for previously intractable solid tumors. We target O-linked glycoproteins specific to cancer cells to develop proprietary, high-affinity antibodies to novel cancer-specific targets. Our antibodies are the basis for a broad array of potent cancer-killing modalities including T-cell bispecifics (TCBs), CAR-T, and antibody drug conjugates (ADCs). Each are designed to kill cancer while sparing healthy tissue.
GO Therapeutics Address
One Broadway
Natick, MA
GO Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.